G. Griffing

发表

Could intranasal insulin be useful in the treatment of non-insulin-dependent diabetes mellitus?

A. McCall, N. Ruderman, J. Melby, 1991, Diabetes research and clinical practice.

Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.

J. Manson, A. McCall, N. Ruderman, 1985 .

Neurointervention and the Endocrinologist: Inferior Petrosal Sinus Sampling

R. Edgell, G. Griffing, S. Mehta, 2015 .

The effects of hydrochlorothiazide on the renin-aldosterone system.

J. Melby, G. Griffing, B. H. Sindler, 1983, Metabolism: clinical and experimental.

Adrenocorticosteroid excretion in salt-sensitive and salt-resistant spontaneously hypertensive rats

J. Melby, G. Griffing, M. Holbrook, 1992, Steroids.

Production rates of androgens and oestrogens in post-menopausal women.

C. Longcope, G. Griffing, W. Jaffee, 1981, Maturitas.

Estrogen replacement therapy at menopause.

G. Griffing, S. H. Allen, 1994, Postgraduate medicine.

ENALAPRIL (MK-421) AND THE WHITE CELL COUNT AND HAEMATOCRIT

J. Melby, G. Griffing, 1982, The Lancet.

Metabolic clearance rates of androgens and oestrogens in ageing women.

C. Longcope, G. Griffing, W. Jaffee, 1980, Maturitas.

Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.

J. Melby, M. Holbrook, G. Griffing, 1983, Hypertension.

Hormone-Secreting Tumors

J. Vaitukaitis, G. Griffing, 1980 .

Enalapril and hypertension.

J. Melby, G. Griffing, L. Cohen, 1984, The American journal of psychiatry.

19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.

J. Melby, M. Holbrook, G. Griffing, 1983, The Journal of clinical endocrinology and metabolism.

Plasma and urinary 19-nor-deoxycorticosterone in 17α-hydroxylase deficiency syndrome

I. Ullrich, J. Melby, T. E. Wilson, 1984 .

Mother was right about cod liver oil.

G. Griffing, 2008, Medscape journal of medicine.

PRODUCTIONRATESOFANDROGENSANDOESTROGENSIN POST-MENOPAUSALWOMEN*

C. Longcope, G. Griffing, W. Jaffee, 1981 .

Adrenocortical Factors in Hypertension

J. Melby, G. Griffing, 1985, Journal of clinical pharmacology.

Phenomenology and family history of affective disorder in Cushing's disease.

H. Pope, J. Melby, J. I. Hudson, 1987, The American journal of psychiatry.

Atenolol and timolol.

S. Rössner, W. Frishman, S. Vožeh, 1982, New England Journal of Medicine.

Characterization of the adrenal 11 beta-hydroxylase in inbred salt-sensitive and resistant rats.

S. Azar, J. Melby, N. Orme-Johnson, 1991, Endocrine research.

Chronic mineralocorticoid excess and cardiovascular remodeling

K. Weber, V. Ganjam, Yao Sun, 1995, Steroids.

Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesis.

J. Melby, G. Griffing, 1989, Metabolism: clinical and experimental.

Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): a new angiotensin-converting enzyme inhibitor.

J. Melby, G. Griffing, B. H. Sindler, 1983, Metabolism: clinical and experimental.

The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.

J. Melby, G. Griffing, J. C. Melby, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Temporal enhancement of renin‐aldosterone blockade by enalapril, an angiotensin‐converting enzyme inhibitor

J. Melby, G. Griffing, B. H. Sindler, 1982, Clinical pharmacology and therapeutics.

Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndrome.

J. Melby, T. E. Wilson, G. Griffing, 1987, The Journal of clinical endocrinology and metabolism.

Primary empty sella syndrome, ACTH hypersecretion, and normal adrenocortical function. Report of two cases.

J. Melby, G. Griffing, B. H. Sindler, 1982, The American journal of medicine.

A-I-D-S: the new endocrine epidemic.

G. Griffing, 1994, The Journal of clinical endocrinology and metabolism.

Hypokalemia, Potassium Supplements, and Potassium-Sparing Agents

J. Melby, G. Griffing, 1986 .

Identification of 19-hydroxy-progesterone in human placenta.

J. Melby, K. Kyei-Aboagye, M. Holbrook, 1988, Journal of steroid biochemistry.

Images in clinical medicine. Frank's sign.

G. Griffing, 2014, The New England journal of medicine.

Comparison of the mineralocorticoid activity of 19-oxygenated and 19-nor derivatives of deoxycorticosterone

J. Melby, T. E. Wilson, G. Griffing, 1991, Steroids.

Renal 21-hydroxylation of 19-hydroxy-progesterone to 19-hydroxy-deoxycorticosterone.

J. Melby, M. Holbrook, G. Griffing, 1989, Journal of steroid biochemistry.

Unconjugated and Conjugated Urinary 19‐Nor‐deoxycorticosterone Glucosiduronate: Elevated Levels in Essential Hypertension

J. Melby, T. E. Wilson, G. Griffing, 1985, Hypertension.

19-Nor-corticosteroids in genetic hypertension. Effects of inhibitors of 11μ,18,19-hydroxylase activity

S. Azar, J. Melby, J. O. Johnston, 1993, The Journal of Steroid Biochemistry and Molecular Biology.

An adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.

J. Melby, R. Egdahl, G. Griffing, 1989, Clinical and experimental hypertension. Part A, Theory and practice.

Converting-enzyme inhibitor administration lowers urinary free 19-nor-deoxycorticosterone levels.

J. Melby, T. E. Wilson, G. Griffing, 1985, Hypertension.

Transitory increment in urinary free 19-nor-deoxycorticosterone after diuretic-induced renin stimulation.

J. Melby, T. E. Wilson, G. Griffing, 1984, The Journal of clinical endocrinology and metabolism.

Mineralocorticoids in Hypertension: 19-Nor-Corticosteroids in Experimental and Human Hypertension

J. Melby, M. Holbrook, G. Griffing, 1984 .

19-Nor-corticosteroids in health, in hypertensive states in humans including 17 alpha-hydroxylase deficiency and in the spontaneously hypertensive rat (SHR).

J. Melby, T. E. Wilson, M. Holbrook, 1984, Endocrine research.

The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.

J. Melby, M. Holbrook, G. Griffing, 1983, The Journal of clinical endocrinology and metabolism.

19-Nor-corticosteroids in experimental and human hypertension.

J. Melby, M. Holbrook, G. Griffing, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Antihypertensive effects of an aromatase inhibitor in the spontaneously hypertensive rat.

J. Melby, J. O. Johnston, M. Holbrook, 1987, Hypertension.

Myelodysplastic Syndromes Associated With Isolated Del (5q)

G. Griffing, S. Bhimji, 2015 .

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-1992. A 23-year-old woman with a painful mass in the right adrenal region.

R. Scully, B. U. Mcneely, J. Eichhorn, 1992, The New England journal of medicine.

Cisplatin-based treatment of adrenocortical carcinoma.

J. Melby, P. Hesketh, R. Mccaffrey, 1987, Cancer treatment reports.

Discordance of plasma DHEA-S, DHEA, and cortisol responses with various ACTH regimens.

J. Melby, H. Pratt, G. Griffing, 1985, Metabolism: clinical and experimental.

The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.

J. Melby, G. Griffing, B. H. Sindler, 1983, The American journal of medicine.

Alterations in aldosterone secretion and metabolism in low renin hypertension.

J. Melby, T. E. Wilson, G. Griffing, 1990, The Journal of clinical endocrinology and metabolism.

Altered fractional tetrahydroaldosterone excretion during pharmacological blockade and activation of the renin-aldosterone system.

J. Melby, T. E. Wilson, G. Griffing, 1982, The Journal of clinical endocrinology and metabolism.

Recurrent Takotsubo Cardiomyopathy Related to Recurrent Thyrotoxicosis.

J. Stolker, P. Hauptman, G. Griffing, 2016, Texas Heart Institute journal.

Escitalopram for Treatment of Night Eating Syndrome: A 12-Week, Randomized, Placebo-Controlled Trial

K. Gadde, J. V. Vander Wal, G. Griffing, 2012, Journal of clinical psychopharmacology.

New therapies for diabetes mellitus

G. Griffing, 2012, Pathy's Principles and Practice of Geriatric Medicine.

Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.

J. Melby, A. Brownie, M. Hudson, 1985, The Journal of clinical investigation.

Elevated 18-hydroxy-corticosterone in inbred salt-sensitive rats.

S. Azar, J. Melby, M. Holbrook, 1991, Clinical and experimental hypertension. Part A, Theory and practice.

Estrogen replacement therapy at menopause. How benefits outweigh risks.

G. Griffing, S. H. Allen, 1994, Postgraduate medicine.

The Effect of Amiloride on the Renin—Aldosterone System in Primary Hyperaldosteronism and Bartter's Syndrome

J. Melby, G. Griffing, B. H. Sindler, 1982, Journal of clinical pharmacology.

"Hyper-warburgism," a cause of asymptomatic hypoglycemia with lactic acidosis in a patient with non-Hodgkin's lymphoma.

S. Albert, G. Griffing, G. Elhomsy, 2012, The Journal of clinical endocrinology and metabolism.

Biphasic Plasma Aldosterone Responses to Four Single‐Dose ACTH Regimens

J. Melby, H. Pratt, George T. Griffing, 1985, Journal of clinical pharmacology.

Effect of peripheral sex steroid metabolism on pituitary gonadotropin reserve of women with hypothalamic amenorrhea.

C. Longcope, R. Redline, J. Vaitukaitis, 1981, Fertility and sterility.

Effectiveness of indapamide versus enalapril as second-step therapy of systemic hypertension.

T. Marbury, J. Schoenberger, G. Griffing, 1992, The American journal of cardiology.

Dinosaurs and steroids.

G. Griffing, 1993, Journal of Clinical Endocrinology and Metabolism.

19-Hydroxylase inhibition of adrenal mitochondrial P450 11 beta/18/19-hydroxylase by a suicide inhibitor.

J. Alberta, J. Melby, N. Orme-Johnson, 1989, The American journal of the medical sciences.

Antihypertensive Effects of an Aromatase Inhibitor in Inbred Salt‐Sensitive Rats

J. Melby, G. Griffing, Monica Holbrook, 1991, Hypertension.

Biphasic 19-nor-deoxycorticosterone excretion after adrenal enucleation is associated with altered adrenal mitochondrial cytochrome P450 11 beta-, 18-, and 19-hydroxylase activities.

H. Bengele, R. Perrone, E. Alexander, 1987, Endocrinology.

Plasma β-Endorphin Levels in Primary Aldosteronism*

J. Manson, T. Mcintosh, J. Melby, 1985 .

Urinary free cortisol and response to the dexamethasone suppression test in bulimia: A pilot study

D. Katz, H. Pope, J. Melby, 1987 .